Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STIM1 antisense RNA 1 (STIM1-AS1) is a long non-coding RNA molecule that acts as a regulator of cellular functions and is implicated in the modulation of calcium signaling pathways. STIM1-AS1 influences cellular behavior, particularly in cancer contexts, by altering the expression or function of STIM1, which is a central protein in calcium entry into cells. The specific mechanistic pathways and additional functional roles remain under investigation, but STIM1-AS1 is associated with cancer progression due to its regulatory effects on calcium signaling and cell physiology[1]. - STIM1-AS1 is not a protein-coding gene and does not function as a canonical therapeutic target (such as a receptor, enzyme, transporter, or transcription factor)[1]. - There are currently no drugs, mechanisms of action, or well-established biomarker roles directly attributed to STIM1-AS1. Its relevance is primarily as a regulatory long non-coding RNA in the context of cellular signaling, especially in cancer[1]. - Information is distinct from the protein-coding gene STIM1, which is a recognized target in calcium signaling research, immune response, and certain diseases[2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STIM1 antisense RNA 1 (STIM1-AS1).